Search Results for: CLINICAL TRIALS Its Time to
Articles
Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin July 27, 2020
Global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions has recently signed an agreement with Moleculin Biotech, Inc., to...Croda Strengthens Position in Life Sciences With Acquisition of Avanti Polar Lipids July 9, 2020
Croda International Plc recently announced it has agreed to acquire Avanti Polar Lipids, Inc., a knowledge-intensive leader in lipid-based drug delivery technologies for next-generation pharmaceuticals…..
2020 Respiratory Drug Development eBook – Inhaled Medications for Treating Unconventional Respiratory Diseases June 30, 2020
This second annual Drug Development & Delivery Respiratory eBook focuses on a few companies that are taking inhalation devices to a new level in drug delivery.
FDA Approves First & Only Oral Somatostatin Analog for Acromegaly June 29, 2020
Chiasma, Inc. recently announced the US FDA approved MYCAPSSA (octreotide) capsules for long-term maintenance treatment in acromegaly patients who have...Glyscend Therapeutics Completes $20.5-Million Financing Round to Advance Novel Oral Polymer Therapy June 17, 2020
Glyscend Therapeutics recently announced the closing of a $20.5-million Series A financing round. Healthcare investors Brandon Capital Partners, through its...Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases June 11, 2020
Ovid Therapeutics Inc. recently announced a strategic research collaboration with Columbia University Irving Medical Center researchers to advance genetic based therapies for……
THERAPEUTIC FOCUS - The Future of Treating Alzheimer’s Disease: Aducanumab & Beyond June 9, 2020
Hermann Russ, MD, PhD, and Alexander Gebauer, MD, PhD, believe the times when amyloid beta as a drug target have been dubbed a dead horse in the race for treatment of Alzheimer’s disease are now over.
SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Specialized Capabilities for Small & Large Molecules June 4, 2020
Contributor Cindy H. Dubin interviews key players in the CDMO market who present case studies about how they are helping pharmaceutical and biopharma companies overcome a variety of formulation and manufacturing challenges.
PFS MANUFACTURING - Prefilled Syringes & Biologics: The Perfect Partnership of Medicine & Delivery June 4, 2020
Anish Parikh charts the twin rise of biologics and PFS, outlines some of the common challenges associated with filling and dispensing, and discusses how a patient-centric partnership approach can help biopharmaceutical companies shorten the development pathway and ensure a reliable supply of safe, effective medicines for the people who need them.
CHIMERIC COMPOUNDS - “Dopastatins”: One Molecule Targeting Two Receptors for the Treatment of Pituitary Tumors June 4, 2020
Heather Halem, PhD, and Michael D. Culler, PhD, believe this novel class of compounds represents a potential treatment for neuroendocrine tumors that are vulnerable to the synergistic dual activation of somatostatin and dopamine receptors.
Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase 2 Study June 2, 2020
Atriva Therapeutics GmbH recently announced a clinical strategy to treat patients with moderate to severe COVID-19 who require hospitalization. ATR-002,...Apellis Initiates Phase 1/2 Study of APL-9 in Patients With Severe COVID-19 June 2, 2020
Apellis Pharmaceuticals, Inc. recently announced the company has initiated a Phase 1/2 clinical study of APL-9, an investigational C3 inhibitor...Thermo Fisher Scientific & CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services June 2, 2020
Thermo Fisher Scientific Inc. and CSL Limited recently announced they have entered into a strategic partnership to help meet the growing demand for biologic therapies while also….
MD Anderson & Innovent Biologics Announce Strategic Rare Cancer Development Collaboration May 19, 2020
The University of Texas MD Anderson Cancer Center and Innovent Biologics, Inc. recently announced a strategic collaboration agreement to co-develop TYVYT (sintilimab injection), Innovent’s anti-PD-1 monoclonal…
Akers Biosciences & Premas Biotech Announce Successful Completion of COVID-19 Vaccine Prototype & Obtained First Images of VLP May 19, 2020
Akers Biosciences, Inc. recently announced that Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic…..
Catalent Partners With Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19 May 13, 2020
Catalent recently welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously announced...AI VIVO Seeks Collaboration Partners to Progress Top-Ranked COVID-19 Therapeutic Candidates May 13, 2020
AI VIVO recently announced it is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified...Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University May 13, 2020
Fortress Biotech, Inc. recently announced that Oncogenuity, Inc. has entered into an exclusive worldwide licensing agreement with Columbia University to develop novel….
Singota Solutions Collaborates With Noveome Biotherapeutics to Manufacture Promising Therapy to Treat Severe Condition in People Infected with COVID-19 May 13, 2020
Singota Solutions has been selected to collaborate with Noveome Biotherapeutics, Inc. to manufacture the ST266 investigational drug product, a biologic being evaluated in….